Lithium toxicity following frusemide administration is reported. The clinical features, possible causative mechanisms, and mallagemellt of the intoxication are discussed.
INTRODUCTION
Lithium carbonate is widely used for the treatment of manic depressive psychosis. Precision in dosage is extremely important as serious toxicity occurs just above the therapeutic range of 0·8 to 1·2 mmol/L (Burrows 1976) . Frequent monitoring of serum lithium levels are therefore necessary.
This communication describes some features of lithium toxicity seen in a patient following the administration of frusemide.
CASE REPORT

History
A 59-year-old man was admitted to hospital for treatment of a fractured hip. He had a history of chronic bronchitis, congestive cardiac failure, and manic depressive illness.
The patient had been receiving lithium carbonate for the past two years. Two weeks prior to the present admission he was discharged from a psychiatric hospital, where he had been an inpatient for a month. Serum lithium examinations during that time showed levels within the therapeutic range. ~ledications on discharge were: lithium carbonate 500 mg/day, haloperidol 4·5 mg/day, benztropine mesylate {j mg/day, cydopenthiazide 0 ·.5 mg/day, and Slow K 3 tablets/day. These medications were ceased when the patient fractured his hip in a fall at home two days before his present admission.
Presentation
On admission the patient was conscious and orientated. Blood taken for investigations revealed normal serum electrolytes, urea and creatinine, and a serum lithium level of 0·3 mmol/L. The next day he became increasingly dyspnoeic. Signs of congestive cardiac failure were present and a chest X-ray showed right basal collapse. Treatment was started with oxygen via a 28% ventimask, salbutamol nebulization, digoxin, and intravenous frusemide 40mg.
Following the administration of frusemide, a diure~is was produced, but the patient became confused and disorientated. The level of conciousness deteriorated, and a few hours later he became deeply comatose with rapid shallow respirations. He was then transferred to the Intensive Care Unit (LC.U.).
I.C.U. Progress
In the LC.U. the blood pressure was 160/ 110 mmHg, pulse rate 120/minute and regular, and rectal temperature was 38 ·5°C. A coarse tremor was observed in both hands, and the patient was spastic in all four limbs, displaying cogwheel rigidity. The deep tendon reflexes were hyperactive, and plantar reflexes were extensor. The abdomen was tense and distended, and bowel sounds were absent. The patient remained comatose with inadequate respiration. There was no response to painful stimuli. Blood gases (Fi0 2 0 ·28) were: pH 7 '30, Pa0 2 53 mmHg, PaC0 2 57 mmHg, Base Excess-5·5 mmol/L.
Endotracheal intubation and intermittent positive pressure ventilation was started. Intravenous fluids were administered according Anaesthesia and Intensive Care, Vol. V, No. 1, February, 1977 to central venous pressure. Cephalothin was given, with magnesium 6 mmol per day. Table 1 shows the results of investigations performed on admission to the LC.U. Blood urea and creatinine levels were elevated. The serum lithium concentration had risen to 2·2 mmolJL. An ECG recording showed inverted T wave changes. The patient improved after therapy and over a few days slowly regained consciousness. The abdominal distension settled and bowel function returned. His respiratory function improved and he was weaned off the ventilator with intermittent mandatory ventilation, and extubated on the 5th day in the LC.U. During this time, he put out large volumes of urine (four to six litres per day) with a low specific gravity.
For the next three days, the patient's sensorium remained impaired. He was confused and disorientated with slurred speech. At times he appeared conscious but remained totally uncommunicative. There were no central localizing signs. He was alebrile and both cardiovascular and respiratory systems were stable. Blood gases breathing air were: pH 7 ·41, Pa0 2 75·9 mmHg, PaC0 2 35 mmHg, Base Excess +0·5 mmolJL. Biochemical investigations were normal. The serum lithium level was 0·1 mmolJL. A lumbar puncture was performed and clear CSF was obtained with a normal pressure and analysis, and with a negative culture. The CSF showed a lithium concentration of 0·1 mmolJL.
A psychiatrist examined the patient and found no suggestion of any functional psychosis. Skull X-ray studies and a brain scan were carried out and showed no abnormalities. An EEG recording showed generalized slow wave activity (dominant theta 5-7 Hz with episodic delta activity).
During the following week, the patient's mental state improved without medication. He gradually became more lucid, less dysarthric, and less rigid. The EEG was repeated after six days and still showed slow wave (subalpha 7 Hz) activity, but the abnormality was much less than the previous recording.
Eighteen days after admission to the LC.U., the fractured hip was corrected surgically without incident. The patient was subsequently transferred to the orthopaedic and rehabilitation wards, and discharged home three months later. Repeated examinations over this time showed no rigidity and dysarthria, but a fine tremor persisted. The patient remained co-operative and orientated.
DISCUSSION
Common side effects of lithium therapy include nausea, vomiting, diarrhoea, muscle weakness and polyuria. Toxicity occurs at levels close to and above 2 mmolJL. Signs of toxicity include drowsiness, slurred speech, muscle rigidity, twitching and coarse tremors. Severe intoxication may lead to coma, convulsions and death. The toxic effect on the central nervous system may persist for several days (Herrero 1973) .
Many of these features were seen in this patient following the administration of frusemide. Lithium therapy had been ceased three days previously and the serum lithium level measured the day before had not been elevated.
Lithium can substitute for sodium and potassium in their distribution in the body (Goodman and GiIman 1970). In the process of depolarization lithium replaces sodium and enters the cell (Carmeliet 1974) . Once intracellular, it impairs the sodium pump, thereby preventing the re-entry of potassium that diffused from the cell during depolarization. As a result, lithium gradually replaces potassium at intracellular sites, and alters the cationic composition of intracellular fluid, so that a variety of metabolic disturbances ensue (Goodman and Gilman 1970) .
The main route of excretion of lithium is through the kidneys. The risk of intoxication is thu,-; increased by renal impairment or by alteration of serum electrolytes. ] t is conceivahlr that a rapid loss of body water, sodium and potassium may precipitate lithium intoxication, although the serum concentration may not he elevated initially. In this reported cas~> fruscmide caused dehyclration and hypovolaemia. The alteration of fluid and electrolytes in body compartments, together with the decrease in renal clearance due to hypovolaemia may then have resulted in toxicity.
The toxic effects were manifested even though the drug had been discontinued for some days. In addition, the features of central neurotoxicity persisted for m'er two weeks. These ohsen:at ions can be explained by the fact that accumulated lithium remains in nerve cells for long periods, and can he pumped out only at Cl slow rate (Keynes and Swan 1!)59, Ciacobini, 1 !Hi!l). The CSF tlms has a slow lithium clearance (l'rockop and :'Iarcus 1972) . Brain lithium concentration may not therefore be reflected hv the serum level. Furthermore, lithium toxicity with brain damage without elevation of ,",crulll lithium levels has been reported (Cohen and C ohen 197 J) following com hined lithium and haloperidol t Iwrapy. Both lithium and haloperidol had been giH>n in tllis present case.
Lithium toxicity has also heen associated with hypothyroidIsm (Emerson, Dyson and l'tiger J97;{, .Tames and Darken ]97(;) and cardiac arrhythmia,; (\ Yorthley ] 97 J). These disorders were not seen in this patient.
Large infusions of sodium have heen advocated in the management of lithium toxicity to increase renal clearance (Thornsen and Schou J !1ti8). This guideline was not followed in this patient because of his cardiac status. Magnesium was given becam:e lithium may induce alterations in brain magnesiulll content and distribution (Birch ]97:5, Essman 1975) . The serum magnesium level was normal but serum magnesium correlates poorly with the total body level, as magnesium is predominantly an intracellular ion.
The paralytic ileus was surprising, as the usual bowel dysfunction of lithium toxicity is that of hyperactivity. However, paralytic ileus is a COllllllon side effect of antipsychotic drugs including haloperidol PI eyers, J awetz and Goldfien J 97 J, Burrows 1976). The anticholinergic action of henztropine could further aggravate the disordered howel motility.
In conclusion, potmt diuretics should be used with caution in patienb recel\'ll1g lithiulll therapy. A normal scrum lithium concentration, or reccllt cessation of the drug ma~' not he safeguards against intoxication in such situations.
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